Coloplast A/S (CLPBY) Stock Price, News & Analysis

Company Overview

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy. The company was established in 1957 by Aage Louis-Hansen and his wife, Johanne Louis-Hansen. Headquartered in Humlebæk, Denmark, Coloplast serves healthcare professionals and patients in markets across Europe, North America, and other international regions. Kristian Villumsen has served as the company’s president and chief executive officer.

Key Stats

• Today's Range: $6.53 to $6.63
• 50-Day Range: $6.18 to $7.40
• 52-Week Range: $5.64 to $9.70
• Volume: 168,261 shs
• Average Volume: 264,435 shs
• Market Capitalization: $14.87 billion
• P/E Ratio: 34.74
• Dividend Yield: 1.21%
• Price Target: N/A
• Consensus Rating: Hold

Coloplast A/S Stock Analysis - MarketRank™

Coloplast A/S scored higher than 35% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Coloplast A/S has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Coloplast A/S has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 2.50%

Earnings Growth

Earnings for Coloplast A/S are expected to grow by 2.50% in the coming year, from $0.40 to $0.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Coloplast A/S is 34.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of Coloplast A/S is 34.74, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.28.

Price to Earnings Growth Ratio

Coloplast A/S has a PEG Ratio of 2.35. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Coloplast A/S has a P/B Ratio of 6.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Coloplast A/S has been sold short.

Short Interest Ratio / Days to Cover

Coloplast A/S has a short interest ratio ("days to cover") of 0.35, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Coloplast A/S has recently decreased by 1.38%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Coloplast A/S pays a meaningful dividend of 1.25%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Coloplast A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Coloplast A/S is 42.11%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Coloplast A/S will have a dividend payout ratio of 19.51% next year. This indicates that Coloplast A/S will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Coloplast A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Coloplast A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Coloplast A/S has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/18/2026
• Today: 10/12/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:CLPBY
• Previous Symbol: NASDAQ:CLPBY
• CIK: 1294325
• Web: www.coloplast.com
• Phone: (454) 911-1111
• Fax: N/A
• Employees: 17,156
• Year Founded: 1957

Profitability

• EPS (Trailing Twelve Months): $0.19
• Trailing P/E Ratio: 34.74
• Forward P/E Ratio: 16.50
• P/E Growth: 2.35
• Net Income: $538.49 million
• Net Margins: 9.68%
• Pretax Margin: 13.97%
• Return on Equity: 39.27%
• Return on Assets: 11.54%

Debt

• Debt-to-Equity Ratio: 1.51
• Current Ratio: 1.56
• Quick Ratio: 0.94

Sales & Book Value

• Annual Sales: $4.13 billion
• Price / Sales: 3.60
• Cash Flow: $0.36 per share
• Price / Cash Flow: 18.41
• Book Value: $1.06 per share
• Price / Book: 6.23

Miscellaneous

• Outstanding Shares: 2,253,670,000
• Free Float: N/A
• Market Cap: $14.87 billion
• Optionable: Not Optionable
• Beta: 0.21